Data I/O (DAIO) Competitors $2.50 +0.03 (+1.21%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.51 +0.01 (+0.40%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DAIO vs. NAUT, ODYS, OWLT, INTT, PRE, AKYA, OPTX, OMIC, OPXS, and AATCShould you be buying Data I/O stock or one of its competitors? The main competitors of Data I/O include Nautilus Biotechnology (NAUT), Odysight.Ai (ODYS), Owlet (OWLT), inTEST (INTT), Prenetics Global (PRE), Akoya Biosciences (AKYA), Syntec Optics (OPTX), Singular Genomics Systems (OMIC), Optex Systems (OPXS), and Autoscope Technologies (AATC). These companies are all part of the "measuring and control equipment" industry. Data I/O vs. Nautilus Biotechnology Odysight.Ai Owlet inTEST Prenetics Global Akoya Biosciences Syntec Optics Singular Genomics Systems Optex Systems Autoscope Technologies Data I/O (NASDAQ:DAIO) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, community ranking, media sentiment and institutional ownership. Which has more risk & volatility, DAIO or NAUT? Data I/O has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Nautilus Biotechnology has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Do analysts rate DAIO or NAUT? Data I/O presently has a consensus price target of $4.00, indicating a potential upside of 60.00%. Nautilus Biotechnology has a consensus price target of $2.42, indicating a potential upside of 208.01%. Given Nautilus Biotechnology's higher possible upside, analysts clearly believe Nautilus Biotechnology is more favorable than Data I/O.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Data I/O 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Nautilus Biotechnology 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals have more ownership in DAIO or NAUT? 37.0% of Data I/O shares are owned by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are owned by institutional investors. 7.3% of Data I/O shares are owned by company insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is DAIO or NAUT more profitable? Nautilus Biotechnology has a net margin of 0.00% compared to Data I/O's net margin of -7.53%. Data I/O's return on equity of -9.05% beat Nautilus Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Data I/O-7.53% -9.05% -6.89% Nautilus Biotechnology N/A -28.85%-24.93% Does the MarketBeat Community believe in DAIO or NAUT? Data I/O received 171 more outperform votes than Nautilus Biotechnology when rated by MarketBeat users. Likewise, 66.79% of users gave Data I/O an outperform vote while only 18.18% of users gave Nautilus Biotechnology an outperform vote. CompanyUnderperformOutperformData I/OOutperform Votes17566.79% Underperform Votes8733.21% Nautilus BiotechnologyOutperform Votes418.18%Underperform Votes1881.82% Does the media refer more to DAIO or NAUT? In the previous week, Data I/O had 1 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 2 mentions for Data I/O and 1 mentions for Nautilus Biotechnology. Nautilus Biotechnology's average media sentiment score of 0.80 beat Data I/O's score of 0.00 indicating that Nautilus Biotechnology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Data I/O 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nautilus Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, DAIO or NAUT? Data I/O has higher revenue and earnings than Nautilus Biotechnology. Data I/O is trading at a lower price-to-earnings ratio than Nautilus Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioData I/O$21.85M1.06$490K-$0.29-8.62Nautilus BiotechnologyN/AN/A-$63.67M-$0.54-1.45 SummaryData I/O beats Nautilus Biotechnology on 9 of the 16 factors compared between the two stocks. Get Data I/O News Delivered to You Automatically Sign up to receive the latest news and ratings for DAIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DAIO vs. The Competition Export to ExcelMetricData I/OInstruments to measure electricity IndustryComputer SectorNASDAQ ExchangeMarket Cap$23.10M$4.14B$25.08B$8.38BDividend YieldN/A0.46%2.90%4.10%P/E Ratio-13.1622.1144.6019.71Price / Sales1.062.382,088.05116.98Price / Cash24.7417.8734.7834.62Price / Book1.113.246.654.50Net Income$490,000.00$135.28M$739.99M$248.18M7 Day Performance0.40%-0.39%-0.99%1.14%1 Month Performance25.63%15.05%14.39%15.20%1 Year Performance-16.11%-8.24%52,549.95%6.56% Data I/O Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAIOData I/O2.0118 of 5 stars$2.50+1.2%$4.00+60.0%-16.1%$23.10M$21.85M-13.16100Positive NewsNAUTNautilus Biotechnology2.3936 of 5 stars$0.72+3.3%$2.42+234.3%-71.7%$91.21MN/A-1.29130Positive NewsGap UpODYSOdysight.Ai1.2914 of 5 stars$5.35-3.6%$10.00+86.9%N/A$87.24M$3.96M-6.2240News CoveragePositive NewsEarnings ReportGap DownOWLTOwlet3.2088 of 5 stars$5.17+6.7%$7.75+50.0%+31.0%$85.56M$78.06M-2.16106Positive NewsINTTinTEST3.1939 of 5 stars$5.99-1.8%$12.00+100.3%-40.4%$74.85M$127.50M26.04320Positive NewsGap DownHigh Trading VolumePREPrenetics Global2.0441 of 5 stars$5.25-2.6%$9.00+71.4%+37.8%$64.08M$30.62M-1.321Positive NewsAKYAAkoya Biosciences1.2328 of 5 stars$1.16+5.5%$3.21+176.6%-50.8%$57.86M$81.67M-0.9890Negative NewsAnalyst ForecastGap UpOPTXSyntec Optics0.9982 of 5 stars$1.50+4.2%N/A-57.4%$55.03M$29.39M0.003Gap DownOMICSingular Genomics SystemsN/A$20.01flat$6.50-67.5%N/A$50.83M$2.91M-0.57220OPXSOptex Systems1.5724 of 5 stars$6.85+2.2%N/A-3.2%$47.24M$35.23M11.2380AATCAutoscope TechnologiesN/A$7.74+1.7%N/A+17.0%$42.45M$12.89M8.8040Negative NewsDividend CutEx-DividendGap Down Related Companies and Tools Related Companies Nautilus Biotechnology Competitors Odysight.Ai Competitors Owlet Competitors inTEST Competitors Prenetics Global Competitors Akoya Biosciences Competitors Syntec Optics Competitors Singular Genomics Systems Competitors Optex Systems Competitors Autoscope Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DAIO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Data I/O Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Data I/O With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DAIO Stock Free DAIO Stock Alerts